Aloe Private Equity
Overview
Aloe Private Equity is a France-based private equity and venture capital firm founded in 2003. The firm focuses on buyouts and growth capital investments in the cleantech, ag-tech, energy, and commercial services sectors across Europe and Asia.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EVerZom | Oct 2025 | Series A | Co-investor |
| AUSTRAL Dx | Jul 2025 | Seed | Lead |
| Allogenica | May 2022 | Seed | Co-investor |
| POLYGON Therapeutics | Nov 2024 | Seed | Co-investor |
Key People
Vivek Tandon
Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Aloe Private Equity based?
Aloe Private Equity is headquartered in Paris, France.
When was Aloe Private Equity founded?
Aloe Private Equity was founded in 2003.
How many portfolio companies does Aloe Private Equity have?
Aloe Private Equity has 4 portfolio companies in Caplight's dataset.
What are some companies in Aloe Private Equity's portfolio?
Portfolio companies visible on Caplight include EVerZom, AUSTRAL Dx, Allogenica, POLYGON Therapeutics.
What was Aloe Private Equity's most recent investment shown here?
Aloe Private Equity's most recent investment in this portfolio sample was in EVerZom in 2025.
What sectors does Aloe Private Equity focus on?
Aloe Private Equity focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Aloe Private Equity focus on?
Aloe Private Equity typically invests at the Early stage.